Clinical Trial Update: Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma

View source ↗

Summary

This document reports the completion of a clinical trial evaluating the frequency of activity limitation in patients with persistent asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Persistent Asthma | Status: COMPLETED